The Pros and Cons of Using a Price/Earnings Ratio

The Pros and Cons of Using a Price/Earnings Ratio

Introduction


You're evaluating the Price/Earnings (P/E) ratio to value stocks, and this outline helps you use it correctly by steering you away from common traps and toward practical fixes; P/E is simple, popular, and often misused. In this piece I'll focus on trailing P/E (based on the last 12 months of earnings) versus forward P/E (based on analyst or company guidance), the main pros and cons, common adjustments like normalized earnings, one-time items, and share-count changes, and clear practical steps you can follow when a P/E looks misleading-so you can act quickly and defintely with less guesswork.


Key Takeaways


  • P/E is a simple, popular screening tool-but treat it as a starting filter, not a final verdict.
  • Know the difference: trailing P/E = last 12 months EPS; forward P/E = consensus next-12-month EPS.
  • Adjust EPS for one-time items, dilution, and share-count changes to avoid misleading P/Es.
  • Triangulate P/E with PEG, EV/EBITDA, price-to-book, and context (growth, margins, leverage).
  • Compare to sector and historical norms and run hypothesis checks (DCF/justified P/E); use P/E to prioritize further research.


What P/E measures and how to compute it


You're comparing stocks using P/E to prioritize research; here's the quick takeaway so you start on the right foot: P/E is the share price divided by earnings per share, a blunt but useful valuation multiple that needs context.

Definition and the formula


P/E = share price ÷ earnings per share (EPS). EPS is the company's net income attributable to common shareholders divided by the number of shares outstanding; use diluted EPS when share count changes or options matter.

Practical steps to compute and check the math:

  • Get the current share price (use close or last trade).
  • Pull EPS from the latest 12-month consolidated income statement.
  • Divide price by EPS; note if EPS is negative (P/E not meaningful).

Best practices: use the same currency and share basis, prefer trailing EPS from audited financials for comparability, and flag companies with one-time gains or losses that skew EPS.

One-liner: P/E is simply price divided by EPS - a per-dollar cost metric.

Trailing P/E versus forward P/E - which to use


Trailing P/E uses actual earnings from the last 12 months (LTM); forward P/E uses consensus expected earnings for the next 12 months (next‑12‑months EPS). Each answers a different question: trailing shows what you paid for past performance; forward shows what you pay for expected performance.

Actionable checks before you trust either number:

  • Confirm the trailing 12 months end date (quarterly cadence matters).
  • Fetch forward EPS from reputable consensus providers (FactSet, Refinitiv, Bloomberg) and note the date of the estimate.
  • Compare both: big divergence signals differing expectations or recent earnings shocks.

What this hides: forward P/E depends on analyst assumptions; trailing P/E hides structural changes like new capital intensity or a recent acquisition. If guidance is sparse, weight trailing more; if the company is stable and analysts converge, forward is more informative.

One-liner: Trailing = past truth, forward = paid hopes - use both to triangulate.

What P/E conveys in plain terms and a quick math example


At its core P/E tells you how many dollars of market value investors place on one dollar of earnings. It's a price per dollar metric, not a direct measure of value without context like growth, margins, or leverage.

Here's the quick math example and how to record it for decisions:

  • Example inputs: share price = $50, EPS = $5.
  • Compute: $50 ÷ $5 = 10x P/E.
  • Record alongside growth and risk: note next‑year EPS estimate and any one-offs.

How to use that 10x: compare to sector median and historical mean; if sector trades at 15x, this stock is cheaper on P/E, but check if earnings are lower quality or declining. If EPS is volatile, calculate a 3‑year average EPS to smooth noise.

One-liner: It shows how much investors pay per dollar of earnings - simple math, useful only with the surrounding facts.


The Pros of Using the Price/Earnings Ratio


You're using the P/E to quickly triage stocks; it's fast, reflects market sentiment, and gives a common yardstick for peers. Use it as a filter, not a verdict.

Simple and quick to calculate


P/E equals share price divided by earnings per share (EPS). If price is $50 and trailing EPS for FY2025 is $5, P/E = 10x. That one-line math gets you a comparable metric in seconds.

Practical steps:

  • Pull closing price (most recent) and trailing 12-month EPS (FY2025 if available).
  • Compute trailing P/E and forward P/E using consensus next-12-month EPS (FactSet, Refinitiv, Bloomberg).
  • Prefer diluted EPS when share-based compensation is material; normalize for one-offs first.

Best practices:

  • Check EPS definition: GAAP vs non-GAAP.
  • Flag negative EPS - P/E is meaningless then.
  • Keep the calc in your spreadsheet for fast screening; save the steps as a macro.

One-liner: Good first filter for stock screens.

Reflects market sentiment and short-term expectations


P/E rises when investors expect higher future earnings or accept higher price for the same earnings. If a stock's P/E moves from 12x to 18x over three months with flat EPS, that's sentiment, not fundamentals.

How to read sentiment signals:

  • Compare trailing vs forward P/E: a big gap implies strong growth expectations.
  • Watch P/E changes around catalysts: earnings beats, guidance raises, M&A news.
  • Pair with volume and price momentum to distinguish lasting re-rating from short squeezes.

What to watch out for: temporary hype, macro shocks, or index flows that lift entire sectors. If P/E jumps without margin improvement, dig deeper - the re-rating may reverse.

One-liner: A rising P/E often signals optimism - verify the earnings story.

Useful for benchmarking against peers, sector, and history


P/E gives a common scale to compare companies. Start by lining up the firm, three direct peers, the sector median, and a market benchmark for FY2025. Example: firm P/E 24x, sector median 16x, market 18x tells you the stock trades at a premium.

Actionable checklist:

  • Select 3-5 closest peers by business mix and margin profile.
  • Calculate trailing and forward P/E for each (use FY2025 data where available).
  • Compute percent premium/discount: (Company P/E / Sector median P/E) - 1.
  • Cross-check with historical band: compare current P/E to 5-year median P/E.

Practical example: if company P/E is 22x and 5-year median is 14x, you're paying a ~57% premium to history; ask why.

One-liner: Use P/E to prioritize which names to research deeper; it points you where value or risk sits.

Next step: pick three stocks, record trailing and forward P/E for FY2025 and sector medians, and send the sheet to you by Friday - owner: you (or your analyst).


Main drawbacks of the Price/Earnings Ratio


Takeaway: P/E is quick but often misleading because swings in reported earnings, accounting choices, and ignored growth or leverage can hide true value.

P/E can mislead if you ignore underlying earnings quality.

Earnings volatility and one-time items


P/E uses reported earnings, so any large one-off gain, loss, or cyclical swing moves the ratio dramatically. That makes P/E a noisy signal for companies in commodity cycles, turnarounds, or with big restructuring items. You need to separate recurring operating earnings from non-recurring items before trusting P/E.

Practical steps and best practices:

  • Collect FY2025 and prior four years of EPS; compute median and mean.
  • Identify one-offs in FY2025 (asset sales, litigation, impairments) and remove them to produce a normalized EPS.
  • Compare normalized EPS to reported EPS and flag >20% divergence for investigation.
  • Cross-check with cash flow per share (operating cash flow ÷ shares) to see if earnings are backed by cash.
  • Use cyclically adjusted earnings (CAPE) for long-cycle industries; for short cycles, use a 3-5 year normalization.

Quick example: if FY2025 reported EPS = $2.00 and a one-time gain = $1.00, normalized EPS = $1.00. At share price $50, reported P/E = 25x, normalized P/E = 50x. That gap changes your whole investment thesis, so defintely document adjustments.

Accounting differences: GAAP versus non-GAAP


Companies present GAAP (standard) and non-GAAP (adjusted) EPS. Non-GAAP can improve comparability but often excludes recurring costs (stock comp, acquisition amortization). P/E based on non-GAAP EPS can understate risk if you accept aggressive adjustments without reconciliation.

Practical steps and best practices:

  • Always pull both FY2025 GAAP EPS and company-reported adjusted EPS; reconcile the adjustments line-by-line from the footnotes.
  • Make adjustments consistent across peers (e.g., always add back stock-based comp or always treat acquisition amortization as real cost).
  • Calculate two P/Es: one on GAAP EPS, one on adjusted EPS; treat the spread >15% as a red flag.
  • Prefer metrics tied to cash (free cash flow per share, EV/EBITDA) when non-GAAP items materially alter EPS.

Example: FY2025 GAAP EPS = $1.20, company reports adjusted EPS = $1.80 after excluding $0.60 stock comp. Question whether those exclusions reflect recurring economics before trusting the lower P/E from adjusted EPS.

Growth and risk blindspots: ignores growth rate and capital structure


P/E says nothing about future growth (g), required return (r), or leverage. Two firms with the same P/E can have very different prospects and risks. Use P/E only after you test implied growth and adjust for capital structure.

Practical steps and best practices:

  • Compute a justified P/E from a simple Gordon-growth form: justified P/E ≈ (1 - payout) / (r - g). Use FY2025 payout and consensus g.
  • Estimate cost of equity (r) via CAPM; if you assume r = 8%, g = 3%, payout = 40%, justified P/E = 0.6 / 0.05 = 12x. Test sensitivity to ±1% in r and g.
  • Use EV/EBITDA or EV/FCF to neutralize capital-structure differences when comparing leveraged vs unleveraged firms.
  • Combine P/E with PEG (P/E ÷ growth) but check PEG assumptions - growth should be forward-looking FY2026 consensus or a 3-5 year analyst average.
  • Stress-test scenarios: recession, margin compression, rising rates - recompute implied P/E under each and note triggers that blow up the valuation.

What this estimate hides: justified P/E is very sensitive to r and g. A 1 percentage-point rise in r or fall in g can halve the justified multiple, so always show the math and the scenario table.


Practical adjustments and complementary metrics


You're using P/E to screen stocks for FY2025 - do three things: use forward P/E from consensus, normalize EPS for one-offs and dilution, and triangulate with PEG, EV/EBITDA, and price-to-book. Do those and P/E stops being a trap and becomes a useful filter.

Use forward P/E for growth expectations; check consensus sources


Start with the direct takeaway: forward P/E uses analysts' next-12-month earnings and reflects expected performance for FY2025, so it's better for growth signals than trailing P/E.

Steps to follow:

  • Get consensus next-12-month EPS from at least two providers (FactSet, Refinitiv, Bloomberg or S&P) and use the median.
  • Compute forward P/E = current price ÷ consensus EPS. Example: price $60 ÷ consensus EPS $3 = 20x.
  • Compare to sector median; if forward P/E is > 30% above the sector median, flag for further review.
  • Watch trend: if consensus EPS falls > 10% over three months, P/E will re-rate materially - re-check assumptions.

Here's the quick math for sensitivity: a +10% EPS revision lowers P/E by roughly 9% at constant price. What this estimate hides: analyst bias and outlier revisions - always cross-check guidance and company disclosures.

One-liner: Forward P/E shows what the market expects for FY2025 - verify the expectations, don't accept them blindly.

Normalize EPS and prefer diluted EPS when relevant


Takeaway: adjust EPS so earnings reflect recurring operations for FY2025 and use diluted EPS when share count moves matter.

Practical normalization steps:

  • Start with GAAP EPS, then add/subtract non-recurring items reported in FY2025 (asset sales, impairments, restructuring, one-time tax items).
  • Use management reconciliation to rebuild adjusted EPS; if management excludes recurring costs, put them back in.
  • When options, convertibles, or recent share issuances matter, use diluted EPS (includes potential shares) - it lowers EPS and raises P/E.
  • Example: GAAP EPS = $2.50, one-time gain = $0.75 → normalized EPS = $1.75. At price $35, GAAP P/E = 14x vs normalized P/E = 20x.

Checks and limits: reconciliations can hide recurring expenses; look at cash flow from operations and free cash flow for FY2025 to confirm earnings quality. If normalized EPS depends on disputed adjustments, treat P/E as provisional.

One-liner: Normalize EPS (and use diluted EPS) so your P/E reflects real, repeatable earnings for FY2025, not accounting noise.

Combine with PEG, EV/EBITDA, price-to-book for a fuller view


Takeaway: P/E misses growth, capital structure, and asset intensity - triangulate with PEG, EV/EBITDA, and P/B using FY2025 inputs.

Metric-by-metric guide:

  • PEG (P/E ÷ growth rate): use forward P/E and analysts' next 3-year CAGR for FY2025-2028. Rule of thumb: PEG ≈ 1.0 is fair; <0.7 can be cheap; > 1.5 needs justification.
  • EV/EBITDA: compute EV = market cap + net debt (FY2025 balance sheet). Use FY2025 EBITDA to avoid earnings distortion. Example: market cap $10,000m + net debt $2,000m → EV = $12,000m; EBITDA = $800m → EV/EBITDA = 15x.
  • Price‑to‑book (P/B): useful for banks, insurers, industrials. Use FY2025 book value per share; P/B > 3x often signals intangible-driven value or overheating.

How to triangulate in practice:

  • If forward P/E is high but EV/EBITDA is moderate and PEG ≈ 1.0, the premium may be growth-priced - dig into revenue and margin durability for FY2025.
  • If P/E is low but EV/EBITDA is high (large net cash or tax shields), check leverage and one-off charges before declaring a bargain.
  • For asset-heavy firms, weight P/B and EV/EBITDA more than P/E; for software, weight PEG and gross margin trends.

One-liner: Don't rely on P/E alone for FY2025 - triangulate across PEG, EV/EBITDA, and P/B to see growth, leverage, and asset signals clearly.


How to apply P/E in decision-making


You're using the Price/Earnings (P/E) ratio to triage investment ideas; this section shows how to test hypotheses, add context, and spot quick red flags so you spend your time on the right names.

Hypothesis test: compare company P/E to sector median and justified P/E from DCF


Start by framing the hypothesis: is Company Name cheap, expensive, or fairly priced relative to peers and fundamentals? Pull trailing and forward P/E for Company Name, the sector median, and at least three peers from a reliable data provider (FactSet, Bloomberg, Refinitiv, or your broker dashboard).

Step-by-step test:

  • Compute market gap: Company Name forward P/E minus sector median forward P/E.
  • Build a simple justified P/E using the Gordon-style formula: P/E = (1 - retention ratio) / (required return - growth rate). Use analyst consensus for next-12-month EPS and consensus long-term growth as g.
  • Compare: if Company Name forward P/E is well above both the sector median and the justified P/E, the market is pricing premium expectations; if well below, test for distress.

Quick math example: Company Name price/forward EPS => forward P/E 18x; sector median forward P/E 15x. Assume payout 40% (retention 60%), required return r = 10%, growth g = 5%. Justified P/E = 0.4 / (0.10 - 0.05) = 8x. Market P/E >> sector and justified → hypothesis: overvaluation; dig deeper.

What this hides: justified P/E is highly sensitive to r and g; small changes can shift multples materially.

One-liner: If Company Name P/E is above both sector median and justified P/E, open a deeper review - don't buy on the headline.

Context check: adjust for growth, margins, leverage, and macro rates


P/E is a price paid per dollar of earnings; context tells you whether that dollar is worth more or less. Adjust P/E with complementary ratios and simple transforms.

  • Growth: compute PEG = P/E ÷ expected EPS CAGR. Example: Company Name P/E 18x, EPS CAGR 12% → PEG = 1.5. PEG ≈ 1 is a rough fairness rule; >1.5 needs justification.
  • Margins and returns: higher margin or ROIC justify higher P/E. Compare operating margin and ROIC vs sector; a persistent +500bp margin advantage can explain multiple expansion.
  • Leverage: convert to enterprise multiples when debt differs. If net debt/EBITDA > 3.0x, equity P/E understates risk; prefer EV/EBITDA for cross-capital-structure comparison.
  • Macro rates: use sensitivity from the Gordon form. With (1 - b)=0.4, r=10%, g=5% → P/E=8x. If r falls to 9%, P/E = 0.4/(0.09-0.05)=10x. Rates move multiples fast.

Practical steps: normalize growth assumptions to the next 3-5 years, convert P/E to PEG and EV/EBITDA, and run a two-scenario sensitivity (r ±100bp, g ±200bp). What this estimate hides: management execution risk and one-off margin boosts from cost cuts or pricing-check sustainability.

One-liner: Adjust P/E for growth, margins, leverage, and macro rates before you decide cheap or expensive.

Red flags: very high P/E with deteriorating margins; very low P/E with heavy write-offs


Use P/E as a red-flag detector, not a verdict. When you see extremes, run a focused checklist to decide whether to proceed or walk away.

  • High P/E + worsening fundamentals - check 5-year trend of operating margin, revenue growth, and free cash flow conversion. If margins fell from 18% to 10% while P/E rose, question sustainability.
  • Low P/E + aggressive adjustments - inspect non-GAAP EPS, one-time gains/losses, and recurring restructuring charges. A 4x P/E with negative operating cash flow is a smoke alarm.
  • Quality of earnings - reconcile net income to operating cash flow and free cash flow for the past three fiscal years; persistent gaps suggest earnings management or working capital stress.
  • Balance sheet risk - review net debt, off-balance items (leases, pensions), and covenants. Net debt/EBITDA moving above 3-4x increases default risk even if P/E looks attractive.

Actionable checklist: pull the last three 10-K/10-Qs, isolate non-recurring items, run a five-year margin table, and calculate FCF conversion. If you can't explain the multiple with sustainable drivers, deprioritize the name.

One-liner: Use P/E to prioritize research, not to conclude buys.

Research: build a 3-stock watchlist and compute trailing and forward P/E, sector median, justified P/E from a simple Gordon test, PEG, and EV/EBITDA by Friday - Owner: You.


Putting P/E into practice


You're trying to close your research loop: use P/E to filter stocks fast, then decide what deeper work to do next. Below I give clear steps you can apply with FY2025 numbers (LTM to FY2025 and consensus next-12 months), practical checks, and a single next-step owner so this doesn't stall.

P/E as a quick, adjusted signal


Use P/E as a one-glance starting point, not a final valuation. Prefer the trailing P/E when you want realized earnings (LTM to FY2025) and the forward P/E when you want market expectations (consensus next-12 months). Always normalize EPS for FY2025 by removing large one-offs and use diluted EPS when share count changes matter.

Steps: 1) Pull LTM EPS ending FY2025 and consensus next-12 EPS; 2) Compute trailing P/E = price / LTM EPS; 3) Compute forward P/E = price / consensus EPS. Example calculation: price $50 / LTM EPS $5 → trailing P/E = 10x. What this hides: one-time gains, cyclical peaks, and accounting changes can make nominal P/E meaningless unless you adjust.

One-liner: P/E is a fast filter - adjust EPS first, then trust the number a little less than your gut (defintely check the details).

Concrete watchlist task: build and record metrics by Friday


Operationalize P/E with a three-stock watchlist and a short checklist you can complete in one session. Pick one growth, one stable, one value name; capture market price at time of check and FY2025 LTM EPS and consensus next-12 EPS. Then record trailing P/E, forward P/E, PEG, and EV/EBITDA.

  • Compute trailing P/E = price / LTM (FY2025) EPS
  • Compute forward P/E = price / consensus next-12 EPS
  • Compute PEG = forward P/E / (consensus annual EPS growth %)
  • Compute EV/EBITDA = (market cap + net debt) / FY2025 EBITDA

Example templates you can copy into a spreadsheet: price $120, LTM EPS $6 → trailing P/E = 20x; forward P/E 18, consensus growth 12% → PEG = 1.5; market cap $10bn, net debt $2bn, EBITDA $1.2bn → EV/EBITDA = 10x. Owner: you - build the watchlist and record these four metrics for three stocks by Friday.

One-liner: Build the list, capture FY2025 figures, and compute four metrics - then pick the top two to dig into further.

Use P/E to prioritize research, not to conclude buys


Turn P/E flags into focused questions. If P/E is high, ask whether growth, margin expansion, or multiple expansion justifies it. If P/E is low, ask whether earnings quality, asset write-offs, or capital structure explain the discount. Triangulate with a simple justified-P/E from a single-stage DCF: justified P/E ≈ 1 / (r - g) using required return r and sustainable EPS growth g.

Example: r = 9%, g = 4% → justified P/E ≈ 1 / (0.09 - 0.04) = 20x. What this estimate hides: sensitivity to r and g, payout policy, and temporary margin shocks. Practical checks: review FY2025 free cash flow, leverage (net debt / FY2025 EBITDA), and recent non-recurring items on the income statement.

One-liner: Use P/E to prioritize deeper work - compute a quick justified P/E, then read the FY2025 notes and the cash flow statement before you decide.


DCF model

All DCF Excel Templates

    5-Year Financial Model

    40+ Charts & Metrics

    DCF & Multiple Valuation

    Free Email Support


Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.